All HEI'sATU DonegalATU Galway-MayoATU SligoDublin City UniversityDun Laoghaire IADTDundalk ITMaynooth UniversityMTU CorkMTU KerryNational College of Ireland (NCI)NCADRoyal College of SurgeonsSETU CarlowSETU WaterfordTeagascTrinity College DublinTUD BlanchardstownTUD GrangegormonTUD TallaghtTUS AthloneTUS LimerickUniversity College CorkUniversity College DublinUniversity of GalwayUniversity of Limerick All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsInthelia - A Novel Method of Treating or Preventing SepsisSepsis is a major challenge in the intensive care unit, where it is one of the leading causes of death. It arises unpredictability and can progress rapidly. Cilengitide, a potent inhibitor prevents bacterial binding to ... pdf 318.3KBNovel Near Infra Red Dyes for the Endogenous Labelling of ExosomesThe recognition of the biological, diagnostic and medical importance of exosomes has given rise to an urgent need for efficient labelling of these extracellular vesicles in ways that do not alter their inherent character... pdf 325KBNovel RNA therapeutic targeting sodium channel genes for the treatment of Genetic epilepsiesGenetic epilepsies caused by mutations to voltage-gated sodium channels do not currently have adequate treatment options. These diseases begin in the early years of life, with infants suffering severe seizures as well as... pdf 295.5KBRapid Acting Pharmaceutical for Infectious Disease (RAPID)Sepsis is a major challenge in the intensive care unit, where it is one of the leading causes of death. It arises unpredictability and can progress rapidly. Cilengitide, a potent inhibitor prevents bacterial binding to ... pdf 318.3KBHighly Selective Inhibitors of HDAC6 for the Treatment of Cancers and Neurodegenerative DiseaseA novel structural class of highly-selective HDAC6 inhibitors. These patented small molecules have a unique non-hydroxamic acid chemical structure. The lead compound BAS-2 has been shown to inhibit glycolysis in triple ... pdf 229.8KB 123 Last Print Bookmark Top